Concord biotech has entered into a Share Purchase Agreement (SPA) with Clean Max Everglades (Clean Max) and Clean Max Enviro Energy Solutions (CMEESPL), whereby the Company will acquire 26% equity shares of Clean Max from CMEESPL. Investing in renewable energy aligns with the Company’s commitment to sustainability and it’s focused efforts to address environmental challenges.
By transitioning to renewable energy sources, the company will reduce its carbon footprint, contributing to global efforts to combat climate change. Additionally, renewable energy offers long-term financial benefits, including reduction in energy costs. This strategic investment reinforces the Company’s commitment to environmental responsibility, ensuring compliance with evolving environmental regulations, and supporting sustainable growth while enhancing operational efficiency.
Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
